EUVIMEDEUVIMED entdecken
Crossref

Splenomegaly and progressive neurologic involvement: Think about Niemann–Pick type C disease

Merve Yoldas Celik iD, Havva Yazici, Fehime Erdem, Ayse Yuksel Yanbolu, Ebru Canda iD, Ebru Sezer, Sema Kalkan Ucar, Huseyin Onay, Ferda Ozkinay, Eser Yildirim Sozmen, Mahmut Coker

Pediatrics International · 2024

DOI: 10.1111/ped.15832 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatrics International, 2024. Verfasst von Merve Yoldas Celik und 10 weiteren Autor:innen. Beteiligte Einrichtung: Medical Faculty, Department of Pediatric Metabolism and Nutrition, Ege University, Izmir, Türkiye. Hauptthemen laut MEDLINE: Niemann-Pick Disease, Type C, Splenomegaly. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Niemann–Pick type C (NPC) disease is a lysosomal storage disease with visceral organ involvement and neurological and psychiatric symptoms. This study presents the clinical and laboratory findings of NPC cases involving three novel variants.

Methods

The clinical and laboratory findings were reviewed retrospectively between February 2006 and December 2022.

Results

There were nine females and five males. The median age of diagnosis of the patients was 5 months (range: 1 month to 38 years). The clinical phenotypes of the patients were early infantile ( n = 7), late infantile ( n = 4), juvenile ( n = 2), and adult ( n = 1). The visceral findings were splenomegaly (100%), hepatomegaly (78.6%), neonatal jaundice (42.8%), and hepatic failure (14.3%). The neurological findings were developmental delay (71.4%), seizures (50%), vertical supranuclear gaze palsy (28.6%), ataxia (28.6%), dysarthria (28.6%), dysphagia (21.4%), dystonia (21.4%). Cataplexy (14.3%) and psychiatric manifestations (14.3%) were recorded in juvenile and adult‐onset patients. Three novel variants were detected (p.Asn524LysfsTer39, p.Val1023Phe, and p.Asn906Tyr). Miglustat treatment was received by 64.3% of patients but had no clear effect on the disease course. The median duration of use was 3 years (with a range from 1–13 years). Miglustat's adverse effects were low platelet count (35.7%) and diarrhea (7.1%).

Conclusions

Niemann–Pick type C disease should be considered in the presence of visceral organ involvement and progressive neurological findings. It is essential to support the diagnosis with laboratory and genetic analysis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Niemann-Pick Disease, Type CSplenomegalyHumansMaleFemaleRetrospective StudiesInfantAdolescentAdultChild, PreschoolChildYoung AdultPhenotype1-DeoxynojirimycinDisease ProgressionNervous System Diseases

Stichwörter der Autor:innen

NPCNiemann–Pick type Cmiglustatneurological involvementsplenomegaly

Substanzen

1-Deoxynojirimycin

Autor:innen und Institutionen

  • Medical Faculty, Department of Pediatric Metabolism and Nutrition, Ege University, Izmir, Türkiye.
  • Medical Faculty, Department of Medical Biochemistry, Ege University, Izmir, Türkiye.
  • Medical Faculty, Department of Medical Genetics, Ege University, Izmir, Türkiye.

ORCID-Profile: Merve Yoldas Celik, Ebru Canda

Zitieren

APA

Yoldas Celik, M., Yazici, H., Erdem, F., Yuksel Yanbolu, A., Canda, E., Sezer, E., Kalkan Ucar, S., Onay, H., Ozkinay, F., Yildirim Sozmen, E., & Coker, M. (2024). Splenomegaly and progressive neurologic involvement: Think about Niemann–Pick type C disease. Pediatrics International. https://doi.org/10.1111/ped.15832

Vancouver

Yoldas Celik M, Yazici H, Erdem F, Yuksel Yanbolu A, Canda E, Sezer E, et al. Splenomegaly and progressive neurologic involvement: Think about Niemann–Pick type C disease. Pediatrics International. 2024. doi:10.1111/ped.15832

BibTeX
@article{YoldasCelik2024,
  author = {Yoldas Celik, Merve and Yazici, Havva and Erdem, Fehime and Yuksel Yanbolu, Ayse and Canda, Ebru and Sezer, Ebru and Kalkan Ucar, Sema and Onay, Huseyin and Ozkinay, Ferda and Yildirim Sozmen, Eser and Coker, Mahmut},
  title = {Splenomegaly and progressive neurologic involvement: Think about Niemann–Pick type C disease},
  journal = {Pediatrics International},
  year = {2024},
  doi = {10.1111/ped.15832}
}
Kostenlos starten →